SC 13G

Company

BioNexus Gene Lab Corp

Filed

October 17, 2023

Accession Number

0001477932-23-007688

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →